aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...

More documents

Recommendations

Info

HBV mkurnalobis efeqturoba HBeAg (+) pozitiur avadmyofebSi fasdeba anti-HBe-is myari serokonversiiT, xolo HBeAg (-) negatiur avadmyofebSi ALT-s myari normalizebiT da HBV dnm-is myari supresiiT(
aiv infeqcia/SidsiT avadmyofebSi C hepatitis virusiT ko-infeqciis marTvis saxelmwifo standarti (protokoli) 1.ganmarteba – C hepatiti adamianis C hepatitis virusiT gamowveuli infeqciuri daavadebaa. aiv infeqcia/Sidsi ewodeba adamianis imunodeficitis virusiT gamowveul infeqciur daavadebas. orive paTogeniT erTdroulad daavadebisas saubaria aiv infeqcia/Sidsis da C hepatitis virusiT koinfeqciaze. 2. kriteriumebi – a) damadasturebeli – aiv infeqcia/Sidsis damadasturebeli kriteriumebia: aiv antisxeulebis arseboba sisxlis SratSi imunoblotingis meTodiT, aiv rnm-is da/an aiv provirusis dnm-is aRmoCena sisxlSi polimerizaciis jaWvuri reaqciis meTodiT; C hepatitis virusiT daavadebis damadasturebeli kriteriumebia: C hepatitis virusis sawinaaRmdego antisxeulebis arseboba sisxlis SratSi imunofermentuli analizis meTodiT da/an C hepatitis virusis rnm-is aRmoCena sisxlSi polimerizaciis jaWvuri reaqciis meTodiT. b) gamomricxavi – aiv infeqcia/Sidsis gamomricxavi kriteriumebia: Aaiv antisxeulebis ararseboba sisxlis SratSi imunofermentuli analizis meTodiT, aiv rnm-is da/an aiv provirus dnm-is ararseboba sisxlSi polimerizaciis jaWvuri reaqciis meTodiT. C hepatitis virusiT infeqciis gamomricxavi kriteriumebia: C hepatitis virusis sawinaaRmdego antisxeulebis ararseboba, da/an C hepatitis virusis rnm-is ararseboba sisxlSi polimerizaciis jaWvuri reaqciis meTodiT. 3. simptomebi da niSnebi a) damadasturebeli - aiv infeqcia/Sidss paTognomuri klinikuri niSnebi ar gaaCnia, igi miekuTvneba laboratoriulad sadiagnozo daavadebebs. simptomebidan SesaZloa gamovyoT: gaxangrZlivebuli cxeleba, gaxangrZlivebuli faRaraTi, limfadenopaTia, aramotivirebuli profuzuli oflianoba, Zlieri saerTo sisuste, aramotivirebuli wonaSi kleba (1 Tvis ganmavlobaSi sxeulis wonis 10% an meti), sxvadasxva gamonayari kansa da lorwovanze, kandidozuri ezofagiti, cns-is atipiuri dazianebebi; C hepatiti mwvave stadiaze ZiriTadad usimptomod mimdinareobs, mxolod SemTxvevaTa 25%-Si SeasaZloa gamovlindes simptomebi: siyviTle, saerTo sisuste, Sardis gamuqeba, ganavlis gaRiaveba, zogjer sxeulis temperatutis momateba, diskomforti muclis RruSi, gulisrevis SegrZneba, Rebineba da sxva intoqsikaciis movlenebi. daavadeba SemTxvevaTa 80%-Si qronikul mimdinareobas Rebulobs da qronikuli C hepatiti praqtikulad xasiaTdeba usimptomo mimdinareobiT, SesaZlebelia gamoxatuli iyos mxolod zogadi saerTo sisuste. aqedan gamomdinare C hepatitic miekuTvneba laboratiriulad dasiagnostiko daavadebebs. 191
Page 1 and 2:
aiv infeqcia/SidsiT avadmyofTa mkur
Page 3 and 4:
sarCevi klinikuri saxelmZRvanelo-re
Page 5 and 6:
3.2.2.cxeleba aiv inficirebulebSi 3
Page 7 and 8:
aiv infeqcia/Sidsis fonze ganviTare
Page 9 and 10:
done mtkicebulebis siZlieris done (
Page 11 and 12:
1.daavadebis definicia Sidsi abrevi
Page 13 and 14:
Sidsi registrirebulia msoflios 216
Page 15 and 16:
egistrirebul SemTxveevaTa 79% saqar
Page 17 and 18:
adamianis imunodeficitis virusis sa
Page 19 and 20:
aiv rnm-is koncentracia plazmaSi mk
Page 21 and 22:
SeuZlebelia da gadamwyveti misi dia
Page 23 and 24:
persistuli generalizebuli limfadeno
Page 25 and 26:
signalis amplifikacia komplementuri
Page 27 and 28:
• vizitamde rezistentobis testis
Page 29 and 30:
• adamianis papilomavirusi (maxvi
Page 31 and 32:
etinitis identifikaciisTvis, rodesa
Page 33 and 34:
cxrili 8 rekomendaciebi arT dawyebi
Page 35 and 36:
arv medikamentebi arseboben Semdegi
Page 37 and 38:
aCveneben, rom pirveladi rezistento
Page 39 and 40:
- tabletebis Cveneba pacientisTvis
Page 41 and 42:
- aqedan gamomdinare, nrti+anrti re
Page 43 and 44:
igulisxmeba im medikamentebis kombi
Page 45 and 46:
X (arv): testebi, romlebic unda Cat
Page 47 and 48:
maRali mgrZnobeloba abakaviri (ABC
Page 49 and 50:
transaminazebis elevacia anrti (all
Page 51 and 52:
ARV toqsiuroba menejmenti nefrotoqs
Page 53 and 54:
xSiri oportonistuli infeqciebia, ma
Page 55 and 56:
cxrilebis wakiTxvis magaliTi 1. cxr
Page 57 and 58:
damateba2. jandacvis msoflio organi
Page 59 and 60:
damateba 4. ZiriTadi informacia ant
Page 62 and 63:
damateba 5. mkurnalobis reJimis dac
Page 64 and 65:
saerTaSoriso saxeli stavudini (d4T)
Page 66 and 67:
mcire mutacia muSaobs kombinaciaSi.
Page 68 and 69:
25. Phillips AN et al. Viral load o
Page 70 and 71:
Suppl 2:S171-176. 73. Altice FL, Mo
Page 72 and 73:
122. Koval CE et al. Immune reconst
Page 74 and 75:
kandidozi dRe yovel dRe - ko-trimoq
Page 76 and 77:
karcinoma (ara SidsTan perikardiuli
Page 78 and 79:
o cxeleba o wonaSi kleba o Ramis of
Page 80 and 81:
indikatorebi filtvis darRveuli funq
Page 82 and 83:
o yvelaze xSirad viTardeba diarea,
Page 84 and 85:
o glukokortikoidebis sistematiuri m
Page 86 and 87:
100 mg/dReSi meore rigis sqemebi am
Page 88 and 89:
o eqspoziciis Sedegad daavadebis ga
Page 90 and 91:
o remisiis miRweva Zalian Znelia da
Page 92 and 93:
qimioTerapiiT (mag : B-ALL reJimi)
Page 94 and 95:
• imunodeficitis mqone pacientebS
Page 96 and 97:
an famcikloviri 500 mg 3-jer dReSi
Page 98 and 99:
• berkitis-tipis limfoma; • naz
Page 100 and 101:
3.2.2. cxeleba aiv inficirebulebSi
Page 102 and 103:
afTozuri wylulebi stomatiti qeiliti
Page 104 and 105:
ganmavlobaSi 2 Tvis manZilze (xelis
Page 106 and 107:
o gamonayari warmodgenilia mravlobi
Page 108 and 109:
20. Chen XM et al. Cryptosporidiosi
Page 110 and 111:
Tavi IV. aiv infeqcia/SidsiT daavad
Page 112 and 113:
inficirebul bavSvebSi (ramdenadac a
Page 114 and 115:
8 igulisxmeba piri, romelsac aReniS
Page 116 and 117:
4.3. daxocili da inaqtivirebuli vaq
Page 118 and 119:
kerebSi A hepatiti erTeuli an mcire
Page 120 and 121:
13 riski maRalia staJirebis periodS
Page 122 and 123:
ganmavlobaSi, xolo SedarebiT ufro s
Page 124 and 125:
4.8. tkipismieri encefalitis vaqcin
Page 126 and 127:
CvenebebiTa da doziT, rogorc imunok
Page 128 and 129:
4.11.2.3. cofis sawinaaRmdego imuno
Page 130 and 131:
ekomendebulia: vaqcina rekomendebul
Page 132 and 133:
8. United States Centers for Diseas
Page 134 and 135:
aiv infeqcia/Sidsis antiretrovirusu
Page 136 and 137:
5. mkurnaloba a) rekomendebuli pirv
Page 138 and 139:
aiv infeqcia/SidsiT daavadebuli bav
Page 140 and 141: joxiseburi TiTebi. Tumca wlebis man
Page 142 and 143: * saWiroa arv preparatebis bavSvebi
Page 144 and 145: laboratoriuli monacemebis kontroli
Page 146 and 147: Tirkmlis funqciuri sinjebi, gulmker
Page 148 and 149: aiv infeqcia/Sidsis fonze ganviTare
Page 152 and 153: 6. reabilitacia da dakvirveba monit
Page 154 and 155: kandidozuri ezofagitis SemTxvevebSi
Page 168 and 169: martivi herpesvirusuli infeqciis mZ
Page 170 and 171: meTodiT, sisxlis saerTo analizi, Rv
Page 172 and 173: )gamomricxavi _ aiv infeqcia/Sidsis
Page 186 and 187: aiv infeqcia/SidsiT avadmyofebSi B
Page 188 and 189: dinamikaSi dakvirveba CD4≥500/mm
Page 192 and 193: ) gamomricxavi - aiv infeqcia/Sidsi
Page 194 and 195: pegilirebuli interferonis da ribavi
Page 196 and 197: i CD4 X X X X X X X X X TSH X X X H
Page 198 and 199: )gamomricxavi - aiv infeqcia/Sidsis
Page 200 and 201: pirveli rigis antituberkulozuri med
Page 202: testebi: • sisxlis saerTo analizi
show all

aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...

Create successful ePaper yourself

Delete template?

Save as template?